EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC , Warfarin and Non‐Anticoagulated Patients

Esther Forkosh iD, David Hakimian, Harold Jacob, Ian M Gralnek, Lior Katz iD, Aviv Talmon

Alimentary Pharmacology & Therapeutics · 2026-10-22

DOI: 10.1111/apt.71063 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2026-10-22. Written by Esther Forkosh and 5 co-authors. Institution: Institute of Gastroenterology and Hepatology, Hadassah Medical Center, and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Cited 2 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Reported outcomes after gastrointestinal bleeding (GIB) in anticoagulated patients are inconsistent, and comparisons with non‐anticoagulated patients are limited. We assessed whether anticoagulation status was independently associated with mortality after GIB and identified predictors of death.

Methods

We analysed 11,387 consecutive adults with acute GIB over 25 years ( n = 500 direct oral anticoagulant [DOAC], n = 353 warfarin, n = 10,534 non‐anticoagulated). All‐cause mortality at 30 days and 1 year was modelled using overlap‐weighted logistic regression, with complete mortality follow‐up through the Israeli National Population Registry.

Results

Anticoagulated patients were older (median age 81.7 [DOAC] and 75.1 [warfarin] vs. 58.4 years), had greater comorbidity and higher crude mortality than non‐anticoagulated patients. After overlap weighting, neither DOAC nor warfarin was significantly associated with mortality (30‐day OR 1.61, 95% CI 0.81–3.21 for DOAC and 1.30, 95% CI 0.56–3.02 for warfarin; 1‐year OR 0.90, 95% CI 0.62–1.31 and 1.08, 95% CI 0.69–1.69). At 30 days, mortality was associated with age, haemodynamic shock (OR 4.25) and Internal Medicine ward admission (OR 4.55); at 1 year, with age, renal failure, Internal Medicine ward admission and inversely with male sex. Anticoagulation was resumed at discharge in 37.8% of survivors.

Conclusions

Neither DOAC nor warfarin was significantly associated with 30‐day or 1‐year mortality after GIB, including when bleeding severity and admitting ward were excluded from the outcome model. Thirty‐day mortality was associated with severity at presentation, whereas 1‐year mortality was associated with underlying patient characteristics. Resumption was not significantly associated with mortality or readmission for recurrent bleeding.

Subjects

Author keywords

direct oral anticoagulantsgastrointestinal bleedinghaemodynamic shockmortalityoverlap weightingwarfarin

Authors and institutions

  • Institute of Gastroenterology and Hepatology, Hadassah Medical Center, and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Ellen and Pinchas Mamber Institute of Gastroenterology and Hepatology, Emek Medical Center, Afula, Israel.
  • Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Center, and Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

ORCID profiles: Esther Forkosh, Lior Katz

Cite

APA

Forkosh, E., Hakimian, D., Jacob, H., Gralnek, I. M., Katz, L., & Talmon, A. (2026). Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC , Warfarin and Non‐Anticoagulated Patients. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71063

Vancouver

Forkosh E, Hakimian D, Jacob H, Gralnek IM, Katz L, Talmon A. Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC , Warfarin and Non‐Anticoagulated Patients. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71063

BibTeX
@article{Forkosh2026,
  author = {Forkosh, Esther and Hakimian, David and Jacob, Harold and Gralnek, Ian M and Katz, Lior and Talmon, Aviv},
  title = {Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC , Warfarin and Non‐Anticoagulated Patients},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71063}
}
Start for free →